Clinical Trials on Conjunctival Melanoma in United Kingdom
Total 2639 results
-
Yousef ZakhariaUniversity of Iowa; ExelixisRecruitingAdvanced Metastatic MelanomaUnited States
-
Northern California Melanoma CenterPfizer; Schering-PloughTerminated
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer InstituteRecruitingMetastatic MelanomaUnited States
-
Saint John's Cancer InstituteTerminatedMetastatic MelanomaUnited States
-
DermTechCompleted
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer CenterTerminatedMetastatic MelanomaUnited States
-
California Pacific Medical Center Research InstitutePfizer; University of California, San FranciscoCompleted
-
Hackensack Meridian HealthNational Cancer Institute (NCI)WithdrawnMelanoma (Skin)United States
-
Northern California Melanoma CenterBayer; Melanoma Research InstituteCompleted
-
Titan PharmaceuticalsTerminated
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedStage III Cutaneous Melanoma | Stage IIIA Cutaneous Melanoma | Stage IIIB Cutaneous Melanoma | Stage IIIC Cutaneous Melanoma | Stage IV Cutaneous MelanomaUnited States
-
St. Jude Children's Research HospitalSchering-PloughActive, not recruitingMalignant MelanomaUnited States
-
Lokon Pharma ABPrecision Oncology LLCCompletedMalignant MelanomaSweden, United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8United States
-
Mayo ClinicActive, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Ludwig Institute for Cancer ResearchInstitute of Cancer Research, United KingdomCompletedMelanomaUnited Kingdom, Australia, New Zealand
-
Mt. Sinai Medical Center, MiamiBayer; Chiron CorporationCompletedMalignant MelanomaUnited States
-
Mayo ClinicMerck Sharp & Dohme LLCTerminatedStage IV MelanomaUnited States
-
M.D. Anderson Cancer CenterGenta IncorporatedCompleted
-
National Cancer Institute (NCI)CompletedHigh-Risk MelanomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedStage IV MelanomaUnited States
-
Elizabeth Buchbinder, MDGenentech, Inc.RecruitingStage IV Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Unresectable Stage III Cutaneous Melanoma | Unresectable Stage IV Cutaneous MelanomaUnited States
-
University of UtahCompletedMelanoma (Skin)United States
-
SciBase ABCompleted
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedMelanoma (Skin)United States
-
Immunocore LtdAstraZenecaCompletedMalignant MelanomaUnited States
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)Italy, France, Spain, Switzerland, United Kingdom, Belgium, Australia, Norway, Poland, Finland, Netherlands, Germany, Israel, Denmark, Serbia, Estonia, Portugal, Russian Federation
-
Mt. Sinai Medical Center, MiamiBayer; Celgene CorporationCompletedMalignant MelanomaUnited States
-
Lynn E. Spitler, MDUniversity of California, San FranciscoCompletedMalignant Melanoma, MetastaticUnited States
-
Genzyme, a Sanofi CompanyUnknownMelanoma (Skin)United States
-
Power Life Sciences Inc.Not yet recruitingStage IV MelanomaUnited States
-
Washington University School of MedicineGenentech, Inc.Terminated
-
California Pacific Medical Center Research InstituteM.D. Anderson Cancer CenterRecruitingMetastatic MelanomaUnited States
-
Baylor Research InstituteTerminatedMalignant Melanoma Stage IVUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMelanoma | Advanced Melanoma | Melanoma Stage IV | Melanoma Stage IIIUnited States
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI)RecruitingMetastatic MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCutaneous MelanomaUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
Lisata Therapeutics, Inc.TerminatedStage IV Melanoma | Stage III MelanomaUnited States
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
VicalCompletedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)Fox Chase Cancer CenterCompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin MelanomaUnited States
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Maria WeiCompleted
-
University of Kansas Medical CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.RecruitingMetastatic Melanoma | Unresectable Melanoma | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Roswell Park Cancer InstituteTerminatedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin MelanomaUnited States
-
Duke UniversityCompletedHigh Risk MelanomaUnited States
-
Richard WuIovance Biotherapeutics, Inc.Active, not recruitingLocally Advanced Melanoma | Stage IV Melanoma | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8United States